Allergan, Apricus Biosciences deal

Allergan granted Apricus exclusive rights to develop and commercialize Vitaros alprostadil in the U.S. Allergan will receive $1

Read the full 186 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE